Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function

Clinical Cardiology

Volumn 23, Issue 6, 2000, Pages 437-441

  Yalçin, Fatih ^a   Aksoy, Fatma G ^b   Muderrisoglu, Haldun ^b   Sabah, Irfan ^b   Garcia, Mario J ^a   Thomas, James D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme inhibition; Atrial natriuretic peptide; Diastolic dysfunction; Hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR; PERINDOPRIL;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; VALVULAR HEART DISEASE;

EID: 0343674735     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230612     Document Type: Article

References (40)

1. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-1779
2. Bonaduce D, Breglio R, Conforti G: Myocardial hypertrophy and left ventricular diastolic function in hypertensive patients: An echo Doppler evaluation. Eur Heart J 1989;10:611-621
3. Fouad-Tarazi FM: Radionuclide ventriculography in the assessment of diastolic function in hypertension. Herz 1990;15:393-398
4. Blasini R, Tiessen V, Schomig A: Functional changes in left ventricular hypertrophy: Diagnosis of impaired diastolic function in patients with hypertension. J Clin Invest 1993;71(suppl 5):46-50
5. Gaasch WH: Congestive heart failure in patients with normal left ventricular systolic function: A manifestation of diastolic dysfunction. Herz 1991;16:22-32
6. Linderer T, Chatterjee K, Parmley WW: Influence of atrial systole on the Frank-Starling-relation and the end-diastolic pressure-diameter relation of the left ventricle. Circulation 1983;67: 1045-1053
7. DeMaria AN, Wisenbaugh TW, Smith MD: Doppler echocardiographic evaluation of diastolic dysfunction. Circulation 1991;84 (suppl 3):1288-1295
8. Dreslinski GR, Frohlich ED, Dunn FG: Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: Atrial emptying index. Am J Cardiol 1981;47:1087-1090
9. de Bold AJ, Bruneau BG, Kuroski-de Bold ML: Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996;31:7-18
10. Ferrari R, Anand I: Neurohumoral changes in untreated heart failure. Cardivasc Drug Ther 1989;3:979-986
11. Fukui K, Iwao H, Nakamura A: Captopril and hydralazine suppress atrial natriuretic peptide (ANP) gene expression in the ventricles of spontaneously hypertensive rat. Biochem Biophys Res Commun 1989;160:310-316
12. Matsubara H, Yamamoto J, Hirata Y: Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats. Circ Res 1990;66:176-184
13. Grandi AM, Venco A, Barzizza F: Double-blind comparison of perindopril and captopril in hypertension. Effects on left ventricular morphology and function. Am J Hypertens 1991;4:516-520
14. Favrat B, Burnier M, Nussberger J: Neutral endopeptidase versus angiotensin-converting enzyme inhibition in essential hypertension. J Hypertens 1995;13:797-804
15. Kim S, Ohta K, Hamaguchi A: Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium-channel antagonist on cardiac gene expressions in hypertensive rats. Br J Pharmacol 1996;118: 549-556
16. Ogawa T, Linz W, Stevenson M: Evidence for load-independent determinants of cardiac natriuretic peptide production. Circulation 1996;93:2059-2067
17. Ueno H, Takata M, Tomita S: The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: Relation to changes in neurohumoral factors. J Cardiovasc Pharmacol 1997;30:643-648
18. Gosse P, Roudaut R, Herrero G: Beta-blockers and angiotensin-converting enzyme inhibitors in hypertension: Effects on left ventricular hypertrophy. J Cardiovasc Pharmacol 1990;16(suppl 5): 145-150
19. Muiesan ML, Agabiti-Rosei E, Romanelli G: Beneficial effects of one year's treatment with captopril on left ventricular anatomy and function in hypertensive patients with left ventricular hypertrophy. Am J Med 1988;84:129-132
20. Devereux RB, Alonso DR, Lutas EM: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458
21. Haendchen RV, Povzhitkov M, Meerbaum S: Evaluation of changes in left ventricular end-diastolic pressure by left atrial two-dimensional echocardiography. Am Heart J 1982;104:740-745
22. Loperfido F, Pennestri F, Digaetano A: Assessment of left atrial dimensions by cross-sectional echocardiography in patients with mitral valve disease. Br Heart J 1983;50:570-578
23. Boissou P, Galen FX, Richalet JP: Effects of propranolol on plasma ANP levels in humans at rest and during exercise. Am J Physiol 1989;257:259-264
24. Janicki JS, Matsubara BB: Myocardial collagen and left ventricular diastolic function. In Left Ventricular Diastolic Dysfunction and Heart Failure, p. 125-40 (Eds. Gaasch WH, LeWinter MM). Philadelphia: Lea & Febiger, 1994
25. Factor SM, Flomenbaum M, Zhao MJ: The effect of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue. J Am Coll Cardiol 1988;12:1582-1589
26. Lerman RH, Apstein CS, Kagan HM, Osmers EL: Myocardial healing and repair after experimental infarction in the rabbit. Circ Res 1983;53:378-388
27. Appleton CP, Hatle L, Popp RL: Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-440
28. Labovitz AJ, Pearson AC: Evaluation of left ventricular diastolic function: Clinical relevance and recent Doppler echocardiographic insights. Am Heart J 1987;114:836-851
29. Nishimura RA, Abel MD, Hatle LK: Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. Part II: Clinical studies. Mayo Clin Proc 1989; 64:181-204
30. Pinamonti B, Zecchin M, Di Lenarda A: Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: An ominous prognostic sign. J Am Coll Cardiol 1997;29(suppl 3):604-612
31. Giannuzzi P, Temporelli PL, Bosimini E: Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 28:383-390
32. Rihal CS, Nishimura RA, Hatle LK: Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 1994;90: 2772-2779
33. Ishida Y, Meisner JS, Tsujioka K, Ishida Y, Meisner JS, Tsujloka K, Gallo JI, Yoran C, Frater RW, Yellin EL: Left ventricular filling dynamics: Influence of left ventricular relaxation and left atrial pressure. Circulation 1986;74:187-196
34. Choong CY, Abascal VM, Thomas JD, Guerrero JL, McGlew S, Weyman AE: Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography. Circulation 1988;78:672-683
35. Thomas JD, Weyman AE: Echo-Doppler evaluation of left ventricular diastolic function: Physics and physiology. Circulation 1991; 84:977-999
36. Bryg RJ, Williams GA, Labovitz AJ: Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 1987;59: 971-974
37. Tomiyama H, Kushiro T, Imai S: Changes in the E/A ratio induced by handgrip-exercise are related to changes in the plasma atrial natriuretic peptide level, but not to changes in brain natriuretic peptide in mild essential hypertension. Jpn Circ J 1995;59:617-623
38. Clozel JP, Kuhn H, Hefti F: Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 1989;7:267-275
39. Kromer EP, Elsner D, Riegger GA: Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats. Am J Hypertens 1991;4: 521-524
40. Nishimura RA, Schwartz RS, Holmes DR Jr: Failure of calcium-channel blockers to improve ventricular relaxation in humans. J Am Coll Cardiol 1993;21:182-188